|
| |
vaccinex c35 Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Vaccinex Incorporated
Recent Publications by Vaccinex Incorporated:. C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. ...
http://www.bioportfolio.com/biocorporate/10721-Vaccinex_Inco...
|
BioWorld Today
28 Feb 2007 ... Also in research at Vaccinex are VX5 for autoimmune disease, C35 for breast cancer (the most advanced internal candidate) and VX50 for ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
C35 (C17orf37) is a novel tumor biomarker abundant...[Mol Cancer ...
Vaccinex, Inc., Rochester, 1875 Mt. Hope Avenue, Rochester, NY 14620, ... a cDNA clone corresponding to a novel gene C35 (C17orf37) was selected by ...
http://www.ncbi.nlm.nih.gov/pubmed/17121940...
|
bcr1961 BCJ Poster presentation C35 overexpression defines subsets ...
... Cancer Research Centre, University of Edinburgh, UK Vaccinex Inc., Rochester , NY, ... C35-overexpressing breast tumours were found to be of two subsets. ...
http://www.biomedcentral.com/content/download/xml/bcr1961.xm...
|
3 selected items - PubMed Results
Vaccinex, Inc., Rochester, 1875 Mt. Hope Avenue, Rochester, NY 14620, ... The C35 gene is located on chromosome 17q12, 505 nucleotides from the 3' end of ...
http://www.ncbi.nlm.nih.gov/pubmed/17121940,15010812,1273900...
|
SBIR STTR Effective 20-APR-05,Phase Type,Fiscal Year,State,Formal ...
SBIR,Phase II,2001,NEW YORK,"VACCINEX, INC.","$445360 ",2,R44CA080440-02," BORRELLO, MELINDA A",C35: A Target for Bladder and Breast Cancer Therapy,"
ZAUDERER ...
http://grants.nih.gov/grants/Funding/fy2001_award.csv...
|
NIH SMALL BUSINESS INNOVATIVE RESEARCH AWARDS Fiscal Year 2002 ...
TOTAL: $593534 NEW YORK, ROCHESTER (ZIP 14620): VACCINEX, INC. Borrello, Melinda A 5R44CA080440-03 $436055 C35: A Target for Bladder and Breast Cancer ...
http://silk.nih.gov/public/cbz2zoz.@www.sbirsttr.fy2002.txt...
|
NIH SMALL BUSINESS INNOVATIVE RESEARCH AWARDS Fiscal Year 2001 Ref ...
TOTAL: $542130 NEW YORK, ROCHESTER (ZIP 14620): VACCINEX, INC. Borrello, Melinda A 2R44CA080440-02 $445360 C35: A Target for Bladder and Breast Cancer ...
http://grants.nih.gov/grants/Funding/sbirsttr01.txt...
|
"SBIR STTR Effective 20-APR-05","Phase Type","Fiscal Year","State ...
"SBIR","Phase II","2002","NEW YORK","VACCINEX, INC.","$ 436055","5","R44CA080440 -03","BORRELLO, MELINDA A","C35: A Target for Bladder and Breast Cancer ...
http://grants.nih.gov/grants/Funding/fy2002_award.csv...
|
|
